These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 27346339)

  • 81. ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients.
    Elgamal AA; Troychak MJ; Murphy GP
    Prostate; 1998 Dec; 37(4):261-9. PubMed ID: 9831223
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.
    Thrall MM; DeLoia JA; Gallion H; Avril N
    Gynecol Oncol; 2007 Apr; 105(1):17-22. PubMed ID: 17208284
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Utility of
    Wang Y; Chow DZ; Ebert E; Tajmir S; Scott JA; Palmer EL
    AJR Am J Roentgenol; 2020 Oct; 215(4):997-1001. PubMed ID: 32569513
    [No Abstract]   [Full Text] [Related]  

  • 84. Whole-body
    Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy.
    Castellucci P; Fuccio C; Nanni C; Santi I; Rizzello A; Lodi F; Franceschelli A; Martorana G; Manferrari F; Fanti S
    J Nucl Med; 2009 Sep; 50(9):1394-400. PubMed ID: 19690023
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
    Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
    BJU Int; 2012 Nov; 110(10):1501-6. PubMed ID: 22502982
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [¹¹C]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy.
    Giovacchini G; Incerti E; Mapelli P; Kirienko M; Briganti A; Gandaglia G; Montorsi F; Gianolli L; Picchio M
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):877-84. PubMed ID: 25697127
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Mediastinal lymph node uptake in patients with prostate carcinoma on F18-choline PET/CT.
    Rietbergen DD; van der Hiel B; Vogel W; Stokkel MP
    Nucl Med Commun; 2011 Dec; 32(12):1143-7. PubMed ID: 22045476
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Advances in imaging in the postoperative patient with a rising prostate-specific antigen level.
    Hricak H; Schöder H; Pucar D; Lis E; Eberhardt SC; Onyebuchi CN; Scher HI
    Semin Oncol; 2003 Oct; 30(5):616-34. PubMed ID: 14571410
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.
    Sollini M; Pasqualetti F; Perri M; Coraggio G; Castellucci P; Roncali M; Boni R; Lazzeri E; Galeandro M; Paiar F; Versari A; Erba PA
    Cancer Imaging; 2016 Aug; 16(1):27. PubMed ID: 27581366
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.
    Torizuka T; Nobezawa S; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Takekuma M; Maeda M; Ouchi Y
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):797-803. PubMed ID: 12029554
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma.
    Mosavi F; Johansson S; Sandberg DT; Turesson I; Sörensen J; Ahlström H
    AJR Am J Roentgenol; 2012 Nov; 199(5):1114-20. PubMed ID: 23096187
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A Prospective Study Comparing
    Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
    J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Malignant lipogenesis defined by
    Regula N; Häggman M; Johansson S; Sörensen J
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2131-2138. PubMed ID: 27392615
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy.
    Kane CJ; Amling CL; Johnstone PA; Pak N; Lance RS; Thrasher JB; Foley JP; Riffenburgh RH; Moul JW
    Urology; 2003 Mar; 61(3):607-11. PubMed ID: 12639656
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer.
    Hoffmann MA; Wieler HJ; Baues C; Kuntz NJ; Richardsen I; Schreckenberger M
    Urology; 2019 Aug; 130():1-12. PubMed ID: 30986486
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Prostate-Specific Membrane Antigen Positron Emission Tomography-Identified Para-aortic Prostate Cancer Recurrence After Surgery and Salvage Radiation Therapy.
    Menzel P; Chang A
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):261-262. PubMed ID: 31047622
    [No Abstract]   [Full Text] [Related]  

  • 98.
    Jani AB; Schreibmann E; Goyal S; Halkar R; Hershatter B; Rossi PJ; Shelton JW; Patel PR; Xu KM; Goodman M; Master VA; Joshi SS; Kucuk O; Carthon BC; Bilen MA; Abiodun-Ojo OA; Akintayo AA; Dhere VR; Schuster DM
    Lancet; 2021 May; 397(10288):1895-1904. PubMed ID: 33971152
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Imaging Biochemical Recurrence After Prostatectomy: Where Are We Headed?
    Bhargava P; Ravizzini G; Chapin BF; Kundra V
    AJR Am J Roentgenol; 2020 Jun; 214(6):1248-1258. PubMed ID: 32130049
    [No Abstract]   [Full Text] [Related]  

  • 100. Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease.
    Parker WP; Davis BJ; Park SS; Olivier KR; Choo R; Nathan MA; Lowe VJ; Welch TJ; Evans JD; Harmsen WS; Zaid HB; Sobol I; Moreira DM; Haloi R; Tollefson MK; Gettman MT; Boorjian SA; Mynderse LA; Karnes RJ; Kwon ED
    Eur Urol; 2017 Mar; 71(3):340-348. PubMed ID: 27597240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.